Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1983 Aug;79(4):947–952. doi: 10.1111/j.1476-5381.1983.tb10540.x

Effect of 6-hydroxydopamine on bovine adrenal chromaffin cells in culture.

S M Kirpekar, J Nobiletti, J M Trifaró
PMCID: PMC2044939  PMID: 6418253

Abstract

The effect of 6-hydroxydopamine on the catecholamine content and cell morphology of bovine adrenal chromaffin cells in culture was investigated. 6-Hydroxydopamine markedly reduced the catecholamine content of the cultured chromaffin cells after 6 and 24 h exposure. The effect was dose-related, with half-maximal depletion occurring at 2.4 X 10(-5) M. Cells exposed to 6-hydroxydopamine for 3 h and then to normal medium without the drug for 3 h more showed the same degree of toxicity as cells exposed to the drug for the entire 6 h. Ascorbate at high concentrations also exhibited toxicity toward chromaffin cells between 6 and 24 h of exposure. 6-Hydroxydopamine produced marked changes in cell morphology. At 1 h the cells appeared normal, at 3 h the processes were markedly shortened, and at 6 h they were completely retracted. On exposure for 24 h there were gross morphological changes and most cells were detached and free-floating in the medium. The toxicity of 6-hydroxydopamine in bovine adrenal chromaffin cells is discussed.

Full text

PDF
947

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANTON A. H., SAYRE D. F. A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther. 1962 Dec;138:360–375. [PubMed] [Google Scholar]
  2. Haeusler G., Haefely W., Thoenen H. Chemical sympathectomy of the cat with 6-hydroxydopamine. J Pharmacol Exp Ther. 1969 Nov;170(1):50–61. [PubMed] [Google Scholar]
  3. Kenigsberg R. L., Trifaró J. M. Presence of a high affinity uptake system for catecholamines in cultured bovine adrenal chromaffin cells. Neuroscience. 1980;5(9):1547–1556. doi: 10.1016/0306-4522(80)90019-6. [DOI] [PubMed] [Google Scholar]
  4. STONE C. A., PORTER C. C., STAVORSKI J. M., LUDDEN C. T., TOTARO J. A. ANTAGONISM OF CERTAIN EFFECTS OF CATECHOLAMINE-DEPLETING AGENTS BY ANTIDEPRESSANT AND RELATED DRUGS. J Pharmacol Exp Ther. 1964 May;144:196–204. [PubMed] [Google Scholar]
  5. Tranzer J. P., Thoenen H. An electron microscopic study of selective, acute degeneration of sympathetic nerve terminals after administration of 6-hydroxydopamine. Experientia. 1968 Feb 15;24(2):155–156. doi: 10.1007/BF02146956. [DOI] [PubMed] [Google Scholar]
  6. Trifaró J. M., Lee R. W. Morphological characteristics and stimulus-secretion coupling in bovine adcrenal chromaffin cell cultures. Neuroscience. 1980;5(9):1533–1546. doi: 10.1016/0306-4522(80)90018-4. [DOI] [PubMed] [Google Scholar]
  7. Uretsky N. J., Iversen L. L. Effects of 6-hydroxydopamine on noradrenaline-containing neurones in the rat brain. Nature. 1969 Feb 8;221(5180):557–559. doi: 10.1038/221557a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES